Panagora Asset Management’s China Pharma Holdings CPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-205
Closed -$33K 2495
2019
Q2
$33K Sell
205
-3
-1% -$482 ﹤0.01% 2180
2019
Q1
$35K Buy
208
+25
+14% +$3.68K ﹤0.01% 2129
2018
Q4
$24K Buy
183
+11
+6% +$1.6K ﹤0.01% 2176
2018
Q3
$18K Sell
172
-94
-35% -$11K ﹤0.01% 2239
2018
Q2
$29K Buy
266
+2
+0.8% +$270 ﹤0.01% 2140
2018
Q1
$42K Buy
+264
New +$47.2K ﹤0.01% 2083

Other funds holding CPHI

Panagora Asset Management's CPHI Position: Q3 2019 in Review

Panagora Asset Management sold out of China Pharma Holdings (CPHI) in Q3 2019, closing a stake of 205 shares — an estimated $33K sold.

Panagora Asset Management first reported a position in CPHI in Q1 2018 and held it in 6 quarters. The position peaked at $42K in Q1 2018. 6 funds tracked by Wall St. Rank hold CPHI as of Q3 2019.

  • Panagora Asset Management reported no remaining China Pharma Holdings position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 205 China Pharma Holdings shares in Q3 2019, an estimated $33K.
  • Panagora Asset Management first reported a position in China Pharma Holdings in Q1 2018 and held it in 6 quarters.
  • Panagora Asset Management's China Pharma Holdings position peaked at $42K in Q1 2018.
  • 6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.